Simvastatin reduces plasma osteoprotegerin in type 2 diabetic patients with microalbuminuria.
Nellemann
Birgitte
B
Medical Department M, Aarhus University Hospital, Aarhus, Denmark.
Gormsen
Lars C
LC
Dollerup
Jens
J
Schmitz
Ole
O
Mogensen
Carl E
CE
Rasmussen
Lars M
LM
Nielsen
Søren
S
D000419:Albuminuria / Q000097:blood; D050197:Atherosclerosis / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000652:urine; D003925:Diabetic Angiopathies / Q000517:prevention & control; D003928:Diabetic Nephropathies / Q000097:blood / Q000188:drug therapy; D004311:Double-Blind Method; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008297:Male; D053244:Osteoprotegerin / Q000097:blood*; D019821:Simvastatin / Q000627:therapeutic use*